Sinergium Biotech

Carcivac

Superficial bladder cancer

bladder cancer

it is the ninth most common cancer worldwide, with around 429,800 new cases diagnosed each year

Immunotherapy with onco BCG vaccine

Intravesical instillation of BCG into the bladder is performed by inserting a catheter through the urethra.The BCG vaccine stimulates an immune response that can destroy cancer cells.

For the treatment of

Flat urothelial cell carcinoma in situ (CIS) of the bladderAs adjuvant treatment after TUR of primary or recurrent superficial papillary urothelial cell carcinoma.